Skip to main content
Veterinary Medicines

Metrocare 250 mg tablets for dogs and cats

Authorised
  • Metronidazole

Product identification

Medicine name:
Metrocare Flavour 250 mg tablets for dogs and cats
Metrocare 250 mg tablets for dogs and cats
Active substance:
  • Metronidazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
  • QP51AA01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • PVC Aluminium Oriented polyamide Aluminium blister packs.Cardboard box of 7 blisters. Pack size 70 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 9 blisters. Pack size 90 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 8 blisters. Pack size 80 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 6 blisters. Pack size 60 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 50 blisters. Pack size 500 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 5 blisters. Pack size 50 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 4 blisters. Pack size 40 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 3 blisters. Pack size 30 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 25 blisters. Pack size 250 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 2 blisters. Pack size 20 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 10 blisters. Packsize 100 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 1 blister. Pack size 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10491/012/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0239/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 29/04/2025
Download